Genetically Engineered Donor T Cells for BMT Immunotherapy: Expression of Trail and PLZF Selectively Enhances GVT and Abrogates GVHD

✍ Scribed by A. Ghosh; A.M. Holland; Y. Dogan; N. Yim; U.K. Rao; L.F. Young; O.M. Smith; R. Jenq; I.-K. Na; J.J. Tsai; N. Singer; M. West; O. Penack; A.M. Hanash; M.G. Sauer; D. Sant'Angelo; M. Sadelain; M.R.M. van den Brink

• Book ID: 116282456
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 57 KB
• Volume: 17
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2010.12.521